Drug class
Serotonin 5-HT4 receptor agonist; gastrointestinal prokinetic agent (withdrawn or restricted in many jurisdictions)
Mechanism of action
Stimulates 5-HT4 receptors on enteric neurons, enhancing acetylcholine release and increasing gastrointestinal motility. Cisapride can prolong cardiac repolarisation through hERG potassium-channel inhibition, creating risk of QT prolongation and serious arrhythmias.
General use cases
- Historical use for severe gastro-oesophageal reflux and delayed gastric emptying; withdrawn or restricted in many jurisdictions due to QT prolongation and potentially fatal ventricular arrhythmias. It should not be represented as a routine currently available treatment.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
